Gap Analysis Before Any Commitment, In Writing
- The method file, validation report and sample chromatograms read before we quote anything
- Missing stability arms, absent ISR and undocumented analyst habits get named on paper
Services
Platforms
Solutions
About Us
Resources
De-Risk Your Method Transfer, Sending Lab to Ours.
Brief PhDs on your method, prior data and timeline.- Gap Analysis Of Your Method File And Validation Report Before You Commit A Budget
- Partial Validation Sized To What Actually Changed, Never A Silent Full Restart
- Cross-Validation And Bridging So Pre-Move And Post-Move Data Stay One Clean Dataset
- Mid-Study Rescues After Failed ISR, QC Trending, Lab Closures And Sudden CRO Exits
Regulated And Inspected By:
What A Transfer At Our Lab Covers, In Both Directions
Moving a method means proving it behaves the same way in a new place. Six components build that proof, whether it comes to us or goes elsewhere.
Mid-Study Rescue With Bridging Built In, Fast
- After a failed ISR or a site closure, bridging runs tie the new data to the old dataset
- Study batches resume cohort by cohort while the paper trail closes behind them cleanly
Partial Validation Sized To What Actually Moved
- New instruments and new analysts revalidate the moved parameters, not the whole method
- Accuracy, precision and sensitivity confirmed on our fleet against the original criteria
Transfers In From Any Lab, Cooperative Or Not
- A complete package is ideal, yet a validation report and raw chromatograms can be enough
- Where the file runs thin, targeted development fills gaps and the report says so plainly
Cross-Validation When Both Labs Keep Running
- Shared incurred samples and QC pools prove the two labs read the same truth in numbers
- The design of record when a second site, a region split or a capacity overflow drives it
Transfers Out, Documented Well Enough To Leave
- Reports written so your next facility, or your CMO, can reproduce the method faithfully
- Your method is never our leverage: what we build for you is documented to travel onward
The Six Reasons Methods Move
Work leaves a lab over an ISR failure, a closure, a long queue, consolidation, reshoring or [SIXTH REASON]. Half a year to a first batch elsewhere is a delay, not a partnership.
-
A Failed ISR
Incurred samples will not reconcile and the study cannot wait for excuses
-
A Lab Exits
Sites close, teams turn over, and the method needs a new home mid-program
-
The Queue
Six months to first batch elsewhere is a timeline, not a partnership
-
Reshoring
Sponsors bringing structures and samples back inside the United States
-
The Price Of Loyalty
Renewal pricing that assumes you will not move, corrected by moving
Ready To Start? Scope Your Method Transfer.
Tailored transfer quote in 2 days.
Changing Labs Mid-Program Should Not Cost You The Program
Transfers fail on undocumented know-how and matrix differences. We interrogate the method before accepting it, then prove it side by side.
Talk Science First? Ask Our Method Transfer Experts.
Discuss prior data, scope and timeline.- The gap analysis lands in days and the plan names its tier in writing, so the decision to move is made on written evidence about your own method rather than on anyone’s reassurance.
- Methods land on like-for-like hardware: twelve LC-MS systems plus MSD, Luminex, ELISA, flow and PCR, with duplicated critical instruments, so the receiving end is never the excuse.
- Rescues run with discretion and speed: no minimum batch size, bridging designed with your QA team, and study samples resuming cohort by cohort while the documentation closes behind them.
5FDA Inspections Behind The Lab Your Method Is Moving Into
12LC-MS Systems, So Your Method Lands On Like-For-Like Hardware
What Does Method Transfer Cost?
The gap analysis prices the plan: partial validation costs a fraction of full revalidation, and the quote names which parameters rerun and why. Transfers never take longer than the full validation clock, usually far less, and a senior scientist replies within two business days.
Your Cost Cannot Move Mid-Study
The quote you approve is the price you pay. Cost cannot move without an SOW addendum you have already approved, which matters most to a sponsor who is moving labs precisely because the last relationship stopped being predictable.
From Sponsors Who Moved Their Work To Us
Two thirds of the 100+ sponsors we work with each year return, and one in three is past a third year, so transferred methods tend to stay.
-
Sr. Associate Dir., Clinical Trials
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
-
VP, Head of Clinical Operations
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
-
Dir., Bioequivalence Testing
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
-
Head, PK
This study, same as all other bioanalytical studies, was completed with top quality and reporting standard with incredible responsiveness.
-
VP, Biomarker Development
NorthEast BioLab is a responsive, collaborative, and reliable partner
-
SVP Quality & Compliance, Biotech
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
Transferring In? Send the Method Summary, Not the SOP.
We'll tell you what re-qualification needs.Why Do Sponsors Move Methods To Us, And Why Do They Stay?
A transfer is an audition under pressure. The gap analysis is calm, the plan is in writing and the method's record travels with it.
What You Receive
- A written gap analysis of your method file before you commit, with the risks named
- A transfer plan that states its tier: partial validation, cross-validation or full
- Equivalence and bridging data your QA team and any future FDA inspector can follow
- An audited report, plus a method file still written to travel if you ever leave us
What We Need From You
- The method file and validation report, with recent chromatograms or raw plate data
- Reference standard and critical reagents, or their sources and lot numbers to chase
- Incurred samples or QC pools whenever cross-validation or bridging is on the table
- The reason for the move, honestly, because rescues get planned differently than growth
A Complete Guide To Achieve Reliable Quantitative LC-MS Measurements
Liquid chromatography-mass spectrometry (LC-MS) combines two highly selective techniques for isolating, measuring, and quantifying analytes in complex mixtures. The LC component differentiates analytes based on their physicochemical characteristics….
A Mid-Study Move After A Failed ISR: A Representative Rescue, Step By Step
The files arrive under CDA, the gaps get named, the bridge runs and the first batch reports. That is how a receiving lab works when the clock is already running.
-
1. The Call
ISR fails at the incumbent lab mid-study; the sponsor needs a receiving lab now
-
2. Files Under CDA
Method, validation report and chromatograms read within days, gaps named
-
3. Plan In Writing
Partial validation scoped to the move, bridging design agreed with QA
-
4. Replication Runs
The method stands up on like-for-like instruments on our floor
-
5. Bridge Proven
Incurred samples reread; old and new data shown to be one dataset
-
6. Cohorts Resume
Study batches restart with the audited trail closed behind them
Why Do Sponsors Choose Us As Their Receiving Lab?
Because the transfer is not finished until the numbers match in our hands, with the comparison documented.
Get Your Transfer Plan Reviewed By PhD Scientists.
Send your plan. We'll flag pitfalls before they cost you.- Five FDA inspections and GLP and GCLP practice behind the lab receiving your method
- Like-for-like hardware across twelve LC-MS systems and the full immunoassay fleet
- Gap analysis first, always: the risks are named in writing before you spend anything
- Discretion and speed for rescues, with bridging designed alongside your own QA team
Regulated And Inspected By:
A Lab Move Should Not Put Your Program At Risk
Send the method file, validation report and reason for the change under CDA. The gap-analysis plan comes back, mapped to the platforms linked below.
Related FAQs
What sponsors ask before moving a method, answered.
Full validation, partial validation or cross-validation: which will we need?
How long does a transfer take?
What if our current lab will not cooperate?
Will regulators accept the transferred data?
Can our old and new data really be treated as one dataset?
Can you also transfer a method out, to a GMP site or another lab?
Our method file is thin. Is that still a transfer?
Explore More Solutions
A transferred method usually brings its program along, and we take on the PK, ADA and biomarker work that follows.
